Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Jesus Soberino (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation
Dr. Jesús Soberino, MD, PhD is a clinical oncologist based in Barcelona, Spain, affiliated with Hospital Quirón Barcelona and the IOB Institute of Oncology at Vall d’Hebron. He has approximately 17 years of experience in oncology.
- Specializes in breast cancer (endocrine therapy) and melanoma (immunotherapy)
- Leads research on hormone-resistance and novel immune treatments
- Provides consultations for both national and international patients
Educational Background
- Medical degree from University of Granada (Spain), 2008
- Residency in Medical Oncology via MIR at Andalusian Health Service, 2009–2013
- Clinical research training at Vall d’Hebron Institute of Oncology (VHIO)
Professional Experience
- Medical Oncologist and Head of Breast Cancer & Melanoma Unit, IOB – Hospital Quirón Barcelona (since 2016)
- Oncologist at Vall d’Hebron University Hospital and VHIO (2015–2016)
- Participated in clinical trials for CDK4/6 inhibitors and immune checkpoint therapies
Academic Contributions
- Regular lecturer at national and international oncology conferences
- Mentors junior oncologists and oncology researchers
- Research focus: overcoming hormone-therapy resistance and developing melanoma immunotherapies
Areas of Expertise
- Hormone-dependent breast cancer—optimizing endocrine treatments
- Management of hormone resistance in metastatic breast cancer
- Melanoma immunotherapy, including new checkpoint inhibitor combinations
- Holistic patient care—monitoring treatment response and side effects
Publications and Research
Dr. Soberino has participated in numerous clinical trials and contributed to scientific literature on breast cancer genomics and immunotherapy. His work includes:
- Research on the approval of palbociclib and ribociclib for metastatic breast cancer
- Studies leading to the approval of pembrolizumab and nivolumab/ipilimumab for metastatic melanoma
- Genomic studies in HER2-positive breast cancer published in EBioMedicine
Profiles available on PubMed and ResearchGate.
Patient Care Philosophy
- Emphasizes clear communication and shared decision-making
- Focuses on comprehensive care—medical needs and quality of life
- Available for online consultations for international patients
- Adopts a holistic approach, attentive to all aspects of patient wellbeing
Professional Affiliations
- Member of Breast Cancer Unit and Melanoma Unit at VHIO and Vall d’Hebron University Hospital
- Accredited by Vall d’Hebron Institute of Oncology
FAQs
- Is Dr. Jesús Soberino board-certified?
- Yes, he is certified in Medical Oncology in Spain and formally accredited through VHIO.
- What types of treatments does he perform?
- He treats breast cancer using hormone therapy and newer immunotherapy regimens for melanoma.
- Does he treat international patients?
- Yes, he offers online consultations and manages care for international patients at Hospital Quirón Barcelona.
- How long is the typical hospital stay?
- Duration varies—many treatments are outpatient; complex cases may require inpatient care with individualized planning.
- What languages does he speak?
- He speaks Spanish and English; hospital support is available in Catalan and other languages.
- Can he help with resistant hormone-positive breast cancer?
- Yes, he specializes in overcoming endocrine therapy resistance and leading related clinical trials.
- Does he provide second opinions?
- Yes, he offers remote second opinions and follow-up consultations internationally.
Certification & Accreditation
